Cardio-kidney-metabolic phenotypes determine residual cardiovascular risk after acute coronary syndromes

19 February 2026 (13:30 - 14:30)
Organised by: Logo
Congress Presentation Part of: Personalised PCI: special populations, innovative devices and tailored therapy Percutaneous Coronary Intervention (PCI) and Surgery EAPCI Premium Access EAPCI Summit 2026 European Association of Percutaneous Cardiovascular Interventions (EAPCI)